Pacira Pharmaceuticals Reaches New 1-Year High at $70.50 (PCRX)
Pacira Pharmaceuticals (NASDAQ:PCRX) shares reached a new 52-week high on Thursday , Stock Ratings Network.com reports. The stock traded as high as $70.50 and last traded at $69.50, with a volume of 814,779 shares changing hands. The stock had previously closed at $61.87.
The stock has a 50-day moving average of $62.4 and a 200-day moving average of $50.08. The company’s market cap is $2.351 billion.
Pacira Pharmaceuticals, Inc is a United States-based pharmaceutical company. The Company develops non-opioid products for postsurgical pain control.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.